CN104524194A - Traditional Chinese medicine composition for treating diabetes - Google Patents
Traditional Chinese medicine composition for treating diabetes Download PDFInfo
- Publication number
- CN104524194A CN104524194A CN201510029626.XA CN201510029626A CN104524194A CN 104524194 A CN104524194 A CN 104524194A CN 201510029626 A CN201510029626 A CN 201510029626A CN 104524194 A CN104524194 A CN 104524194A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- medicine composition
- taken
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating diabetes. The traditional Chinese medicine composition is characterized by comprising the following components by dosage: 30-50g of astragalus membranaceus, 20-30g of radix pseudostellariae, 20-30g of adenophora stricta, 20-30g of dried radix rehmanniae, 20-30g of rhizoma anemarrhenae, 30-50g of radix ophiopogonis, 15-20g of coptis chinensis, 20-30g of poria cocos, 20-30g of puerarin, 20-30g of Chinese yam, 20-30g of endothelium corneum gigeriae galli, 20-30g of schisandra chinensis, 20-30g of radices trichosanthis, 15-20g of rhizoma alismatis, 20-30g of polygonatum kingianum, 15-30g of salviae miltiorrhizae and 20-30g of ants. The medicines are taken as a group; the group of medicines is decocted with water for three times, is mixed together, and is taken for three times a day; one group of medicines is taken every day; seven days are taken as a treatment course; and a relatively good curative effect can be obtained after the medicine composition is taken for 1-2 treatment courses.
Description
Technical field
The invention belongs to medical domain, be specifically related to a kind of Chinese medicine composition for the treatment of diabetes.
Background technology
Diabetes are with thirsty polydipsia, food of receiving increases, hydrouria, body constitution is become thin, lose weight as cardinal symptom, be commonly called as " three-many-one-little ", in clinical, also with or without " three-many-one-little " symptom, because free insulin in blood and bound insulin increase, anti-insulin principle short of money increases, the change of insulin synthesis character, cause blood glucose, increasing of glucose in urine, the traditional Chinese medical science is called diabetes, be divided into: on, in, lower three disappear, this disease has a strong impact on the quality of life of patient, western medical treatment is mainly with antidiabetic drug long-term taking, insulin injection is primary treatments, but drug side effect is large, late result is not good, medical expense is higher, very large misery and financial burden is brought to patient and family members.
Summary of the invention
In order to more effectively treat diabetes, I in conjunction with theory of Chinese medical science, sums up a kind of Chinese medicine composition for the treatment of diabetes through a large amount of clinical trials.
The technical scheme that the present invention solves its technical problem is:
A kind of Chinese medicine composition for the treatment of diabetes, it is characterized in that: every part of medicine composition and dosage are: Radix Astragali 30-50 gram, Radix Pseudostellariae 20-30 gram, Radix Adenophorae (Radix Glehniae) 20-30 gram, Radix Rehmanniae 20-30 gram, Rhizoma Anemarrhenae 20-30 gram, Radix Ophiopogonis 30-50 gram, Rhizoma Coptidis 15-20 gram, Poria 20-30 gram, Radix Puerariae 20-30 gram, Rhizoma Dioscoreae 20-30 gram, Endothelium Corneum Gigeriae Galli 20-30 gram, Fructus Schisandrae Chinensis 20-30 gram, Radix Trichosanthis 20-30 gram, Rhizoma Alismatis 15-20 gram, Rhizoma Polygonati 20-30 gram, Radix Salviae Miltiorrhizae 15-30 gram, Formica fusca 20-30 gram.
Said medicine is one group, and mix after one group of medicine decocting three times, every natural gift are taken for three times, one day one group, 7 days is a course for the treatment of, takes 1-2 the course for the treatment of, generally can receive good curative effect.
The main pathogenesis of diabetes is; Polyphagia rich and fatty diet, impairing the spleen and stomach, dysfunction of the spleen in transportation and transformation or overaction of the five emotions, hyperactivity of YANG due to deficiency of YIN or weakened defensive QI, pathogenic factor is taken advantage of a weak point and causes a disease.
Fang Zhong: the Radix Astragali, Radix Pseudostellariae supplementing QI and nourishing YIN, there is the effect of two-way conciliation blood glucose, Formica fusca is a kind of efficient immunostimulant and security immunization inhibitor, scalable endocrine regulation, strengthen sugar, protein, the metabolism of fat, activate cell functions, thus raising insulin active, suppress the generation of insulin antibody, Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, the meridian dredging, blood pressure lowering, blood sugar lowering, improve microcirculation, Rhizoma Dioscoreae, Poria replenishing QI to invigorate the spleen, there is antiinflammatory, reduce cholesterol, blood sugar lowering and immunoregulation effect, the Radix Rehmanniae, Rhizoma Coptidis, the Rhizoma Anemarrhenae, Rhizoma Alismatis replenishing YIN and removing heat, pathogenic fire reducing, share and there is hypoglycemic effect, Rhizoma Polygonati tonifying the lung, spleen, deficiency of the kidney yin, nourishing YIN and clearing away heat blood sugar lowering, Radix Adenophorae (Radix Glehniae), Radix Puerariae, Fructus Schisandrae Chinensis, Radix Trichosanthis, heat clearing away Radix Ophiopogonis, promote the production of body fluid, quench the thirst, obvious reducing effect is had to hyperglycemia, Endothelium Corneum Gigeriae Galli is aid digestion, change carnivorous, have and extend stomach moving period, increase the effect of wriggling, there is reduction blood glucose, triglyceride, reduce the effect that mesenteric fat is piled up.
The effectiveness of this medicine is further illustrated below by clinical treatment case:
Curative effect mark mark is drafted according to country's " disease of tcm Standardization of diagnosis and curative effect " diabetes criterion of therapeutical effect of being correlated with: effectively: clinical symptoms is controlled, and blood glucose declines >=49.5%, and glucose in urine is qualitative be the positive; Take a turn for the better: blood glucose decline >=35-40%; Glucose in urine qualitative (++) below; Invalid: clinical symptoms is not improved, the change of blood glucose, glucose in urine is not obvious.
In order to further illustrate the effectiveness of this medicine, patient is divided into treatment group and matched group, treatment group 95 example, adopt this medicine to treat, every day one group, every natural gift are taken for three times, through taking of two courses for the treatment of, its result is: effective 44 examples, and take a turn for the better 47 examples, invalid 4 examples, total effective rate 96%, matched group 66 example, metformin diabetes pill is taken in employing, after 14 days take, and effective 15 examples, take a turn for the better 32 examples, invalid 19 examples, total effective rate 81%.
Contrasted by above clinical treatment outcome, the curative effect for the treatment of group is obviously better than matched group, illustrates that the curative effect of this Chinese medicine composition is fairly obvious.
This beneficial effect of the invention is: develop motherland's traditional medicine, and utilize Chinese traditional herbs to carry out reasonable compatibility, treatment cost is lower, and side effect is less, and therapeutic effect is remarkable.
Diabetic duration is slow, more can cause QI and blood deficiency for a long time and not, blood-stasis internal-depression, circulatory disturbance, tissue ischemia, anoxia and produce various disease conditions, we have supplementing QI and nourishing YIN, tonifying speen and tonifying kidney, promoting blood circulation to remove obstruction in the collateral, improve immunologic function, adjustment endocrine, hypoglycemic effect, for QI and blood deficiency, blood stasis resistance network, the diabetes of endocrine disturbance, adhere to taking, and can receive good therapeutic effect.
Detailed description of the invention
Using following medicine as one group: the Radix Astragali 40 grams, Radix Pseudostellariae 25 grams, Radix Adenophorae (Radix Glehniae) 25 grams, 25 grams, the Radix Rehmanniae, the Rhizoma Anemarrhenae 25 grams, Radix Ophiopogonis 40 grams, Rhizoma Coptidis 15 grams, 25 grams, Poria, Radix Puerariae 25 grams, Rhizoma Dioscoreae 25 grams, Endothelium Corneum Gigeriae Galli 25 grams, Fructus Schisandrae Chinensis 25 grams, Radix Trichosanthis 25 grams, Rhizoma Alismatis 15 grams, Rhizoma Polygonati 25 grams, Radix Salviae Miltiorrhizae 20 grams, Formica fusca 25 grams of decoctings three times, mix, one natural gift three times are taken, it within 7 days, is a course for the treatment of, serve on two courses for the treatment of, generally can receive good curative effect.
Claims (1)
1. treat the Chinese medicine composition of diabetes for one kind, it is characterized in that: every part of medicine composition and dosage are: Radix Astragali 30-50 gram, Radix Pseudostellariae 20-30 gram, Radix Adenophorae (Radix Glehniae) 20-30 gram, Radix Rehmanniae 20-30 gram, Rhizoma Anemarrhenae 20-30 gram, Radix Ophiopogonis 30-50 gram, Rhizoma Coptidis 15-20 gram, Poria 20-30 gram, Radix Puerariae 20-30 gram, Rhizoma Dioscoreae 20-30 gram, Endothelium Corneum Gigeriae Galli 20-30 gram, Fructus Schisandrae Chinensis 20-30 gram, Radix Trichosanthis 20-30 gram, Rhizoma Alismatis 15-20 gram, Rhizoma Polygonati 20-30 gram, Radix Salviae Miltiorrhizae 15-30 gram, Formica fusca 20-30 gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510029626.XA CN104524194B (en) | 2015-01-21 | 2015-01-21 | Treat the Chinese medicine composition of diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510029626.XA CN104524194B (en) | 2015-01-21 | 2015-01-21 | Treat the Chinese medicine composition of diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104524194A true CN104524194A (en) | 2015-04-22 |
CN104524194B CN104524194B (en) | 2017-08-15 |
Family
ID=52839950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510029626.XA Expired - Fee Related CN104524194B (en) | 2015-01-21 | 2015-01-21 | Treat the Chinese medicine composition of diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524194B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412566A (en) * | 2015-12-10 | 2016-03-23 | 天津百玛生物科技工程有限公司 | Composition for treating type-2 diabetes mellitus |
CN106138608A (en) * | 2016-07-27 | 2016-11-23 | 戴道强 | A kind of treat the Chinese medicine composition of diabetes, preparation and preparation method thereof |
CN106491990A (en) * | 2016-12-05 | 2017-03-15 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
CN107441406A (en) * | 2017-08-16 | 2017-12-08 | 武汉钧安制药有限公司 | Treat Chinese medicine preparation of type II diabetes and preparation method thereof |
CN114224973A (en) * | 2022-01-13 | 2022-03-25 | 孙天森 | Traditional Chinese medicine composition for treating diabetic ketosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101352512A (en) * | 2007-07-27 | 2009-01-28 | 北京亚东生物制药有限公司 | Chinese medicine composition for treating diabetes and method for preparing the same |
CN102772704A (en) * | 2012-08-15 | 2012-11-14 | 殷广全 | Medicament for treating geriatric disease |
-
2015
- 2015-01-21 CN CN201510029626.XA patent/CN104524194B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101352512A (en) * | 2007-07-27 | 2009-01-28 | 北京亚东生物制药有限公司 | Chinese medicine composition for treating diabetes and method for preparing the same |
CN102772704A (en) * | 2012-08-15 | 2012-11-14 | 殷广全 | Medicament for treating geriatric disease |
Non-Patent Citations (2)
Title |
---|
常红芳: "中西医结合治疗2 型糖尿病临床观察", 《中国误诊学杂志》 * |
陈大舜等: "2 型糖尿病及并发症23139例调研分析研究", 《中医药学刊》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412566A (en) * | 2015-12-10 | 2016-03-23 | 天津百玛生物科技工程有限公司 | Composition for treating type-2 diabetes mellitus |
CN106138608A (en) * | 2016-07-27 | 2016-11-23 | 戴道强 | A kind of treat the Chinese medicine composition of diabetes, preparation and preparation method thereof |
CN106491990A (en) * | 2016-12-05 | 2017-03-15 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
CN106491990B (en) * | 2016-12-05 | 2019-09-03 | 童守信 | A kind of Chinese medicine composition for treating diabetes B |
CN107441406A (en) * | 2017-08-16 | 2017-12-08 | 武汉钧安制药有限公司 | Treat Chinese medicine preparation of type II diabetes and preparation method thereof |
CN114224973A (en) * | 2022-01-13 | 2022-03-25 | 孙天森 | Traditional Chinese medicine composition for treating diabetic ketosis |
Also Published As
Publication number | Publication date |
---|---|
CN104524194B (en) | 2017-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101502619A (en) | Chinese medicine for treating chronic renal failure | |
CN104524194A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN101596230A (en) | A kind of pharmaceutical composition for the treatment of hepatopathy | |
CN101125173A (en) | Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication | |
CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
CN103920074A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
CN104042841A (en) | Traditional Chinese medicine preparation for treating hyperlipidemia | |
CN101940759B (en) | Traditional Chinese medicine composition for treating liver diseases and preparation method and application thereof | |
CN100509025C (en) | A medicine for treating diabetes | |
CN1255358A (en) | Chinese medicine for treating diabetes | |
CN101569740A (en) | Traditional Chinese medicine for curing type II diabetes and preparation method thereof | |
CN100502928C (en) | Traditional Chinese medicine composition for treating hepatocirrhosis and liver ascites | |
CN103830547A (en) | Traditional Chinese medicine for treating diabetes | |
CN101612251B (en) | Traditional Chinese medicine for treating primary liver cancer | |
CN105535855A (en) | Traditional Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
CN102335365A (en) | Liver-nourishing toxin-expelling powder | |
CN103285323A (en) | Traditional Chinese medicine for treating astriction | |
CN100348236C (en) | Medicine for treating diabetes | |
CN102908446A (en) | Traditional Chinese medicine preparation used for controlling severe acute pancreatitis and acute lung injury complications | |
CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis | |
CN106668390B (en) | Traditional Chinese medicine composition for treating hyperthyroidism in early and middle stages | |
CN106511903B (en) | The composition for assisting diuretic therapy senile hypertension, improving compliance problem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170815 Termination date: 20200121 |
|
CF01 | Termination of patent right due to non-payment of annual fee |